At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 45 enrolled
Drug / intervention
vitamin D3dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Double Blind, Randomized, Phase 4, Clinical Trial of The Effects of Vitamin D Supplementation on Patients With Type 2 Diabetes and Vitamin D Deficiency
In Brief
A Phase 4 clinical trial evaluating vitamin D3 for Diabetes Mellitus and Vitamin D Deficiency. Completed, enrolled 45 participants across 1 site.
Detailed Summary
Vitamin D plays a key role in keeping normal mineral balance and maintaining bone health. There is accumulating evidence linking deficient vitamin D status with both type 1 and type 2 diabetes. The purpose of this study is to evaluate the effect of high dose vitamin D supplementation (120000 units per month)for 6 months on glucose homeostasis and glycemic control,in vitamin D deficient patients with non-optimally controlled type 2 diabetes mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Vitamin D Deficiency
CountriesIsrael
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 2013
Enrollment StartDec 2013
Primary CompletionDec 2017
Study CompletionJan 2018
TodayJul 2026
First PostedNov 25, 2013
Enrollment StartDec 1, 2013
Primary CompletionDec 1, 2017
Study CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 12.6 years ago
Interventions
vitamin D3dietary